CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Clinical trials for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) trials appear
Sign up with your email to follow new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a High-Fat, Low-Carb diet help men breathe easier with COPD?
Disease control CompletedThis pilot study investigates whether an 8-week ketogenic diet—high in fat and very low in carbs—can improve lung function, reduce inflammation, and boost exercise capacity in men aged 40–75 with mild-to-moderate COPD. Participants are randomly assigned to either the ketogenic di…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Agri Ibrahim Cecen University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New Real-World study tests triple inhaler for COPD relief
Disease control CompletedThis completed study followed 152 COPD patients who started using a triple-combination inhaler (BGF) as part of their routine care. Researchers measured changes in symptoms and quality of life after 12 and 24 weeks. The goal was to see if the inhaler helps patients feel better an…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for COPD patients: drug aims to cut severe Flare-Ups
Disease control CompletedThis study tested a drug called tozorakimab in over 1,700 people with COPD who had a history of flare-ups. The goal was to see if it could safely reduce severe breathing attacks over the long term. Participants who completed earlier trials were given either tozorakimab or a place…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Simple supplements may fight muscle loss in COPD
Disease control CompletedThis completed study tested whether omega-3 fatty acids and vitamin D supplements can improve weight, muscle mass, and fatigue in 45 people with COPD who also have cachexia (severe muscle wasting). Participants took the supplements twice daily for six weeks. The goal was to see i…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Safeer Khan • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Triple inhaler shows promise for COPD sufferers
Disease control CompletedThis phase 3 trial tested a new triple-combination inhaler (beclometasone, formoterol, and glycopyrrolate) against a standard two-drug inhaler in 1,368 adults with severe COPD. The study measured changes in lung function and breathlessness over 52 weeks. The goal was to see if th…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New shot could cut COPD attacks in former smokers
Disease control CompletedThis study tested two doses of a drug called tozorakimab in over 1,100 adults with COPD who had frequent flare-ups. Participants received either the drug or a placebo as a shot, while continuing their usual inhalers. The main goal was to see if the drug could reduce the number of…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New shot aims to slash COPD attacks in former smokers
Disease control CompletedThis study tested a new medicine called tozorakimab in over 1,100 adults with COPD who had frequent or severe flare-ups. Participants received either a low or high dose of the drug or a placebo as a shot under the skin, while continuing their usual inhalers. The main goal was to …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New COPD inhaler shows promise in large trial
Disease control CompletedThis Phase 3 study tested a new inhaler called HL231 in 487 Chinese adults with moderate to very severe COPD. Participants used either HL231 or the active comparator Ultibro once daily for 52 weeks. The main goal was to see if HL231 improved lung function (FEV1) after 26 weeks co…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
COPD inhaler showdown: which triple therapy wins?
Disease control CompletedThis study compared two different triple-combination inhalers (BGF and FUV) in 22 people with stable COPD. The goal was to see which one better improves small airway function. Participants used each inhaler for a period and then switched, allowing a direct comparison of their eff…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE4 • Sponsor: Thammasat University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a daily Under-the-Tongue vaccine tame COPD flare-ups?
Disease control CompletedThis study tested whether a bacterial vaccine called MV130, taken daily under the tongue for 12 months, can reduce the number and severity of COPD flare-ups in adults with moderate to severe COPD. A total of 198 participants were randomly assigned to receive either MV130 or a pla…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE2, PHASE3 • Sponsor: Inmunotek S.L. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New inhaler for COPD patients put to the test in safety trial
Disease control CompletedThis study tested a new inhaler (BGF MDI HFO) delivering a triple-drug combination (budesonide, glycopyrronium, formoterol fumarate) against the current inhaler (BGF MDI HFA) in 559 people with moderate to very severe COPD. The main goal was to compare safety over 12 weeks, with …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 26, 2026 19:16 UTC
-
Short exercise program shows promise for women with COPD
Symptom relief CompletedThis study looked at whether a 4-week program of breathing muscle training, aerobic exercise, or both could improve breathing strength, walking ability, and well-being in women with stable COPD. 68 women aged 48-65 with mild-to-moderate COPD took part. The researchers also checke…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Mehmet İsmail TOSUN • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New breathing device may offer alternative for COPD emergencies
Symptom relief CompletedThis study tested a new breathing support method (HVNI) against standard non-invasive ventilation (NIV) in 66 COPD patients with dangerously high carbon dioxide levels. The goal was to see if HVNI could safely lower carbon dioxide and reduce the need for a breathing tube. Results…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Al-Azhar University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Which breathing technique works best for COPD? new study finds out
Symptom relief CompletedThis study looked at two different breathing exercises for people with COPD, a long-term lung disease. 58 adults were split into two groups: one used a device that creates vibrations while breathing out, and the other used a special breathing technique. The goal was to see which …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Adnan Hashim • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Smart ventilator feature aims to ease nighttime breathing problems
Symptom relief CompletedThis study tested a new automatic setting (Auto-EPAP) on a ventilator to see if it could better manage airway blockages during sleep compared to the standard manual setting. It involved 23 adults with conditions like sleep apnea, COPD, or obesity-related breathing problems who al…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Breas Medical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New COPD drug shows promise in Real-World romanian study
Symptom relief CompletedThis study followed 10 people with moderate to severe COPD in Romania who started taking the inhaler TRIXEO AEROSPHERE. Researchers measured changes in their health status and treatment satisfaction over 3 and 6 months. The goal was to see how the medication works in everyday lif…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: AstraZeneca • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Minty fresh hope: l-menthol may ease COPD breathlessness
Symptom relief CompletedThis study tested whether L-menthol, a minty compound, can reduce breathlessness and improve exercise ability in people with COPD. Twenty adults with stable COPD cycled while researchers measured their breathing discomfort and endurance. The goal was to see if a simple, natural s…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE2 • Sponsor: Region Skane • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Breathe better in 30 seconds: 4-7-8 technique tested for COPD
Symptom relief CompletedThis study tested whether adding a specific breathing technique called 4-7-8 breathing to standard COPD care can reduce shortness of breath, improve lung function, and boost quality of life. Forty adults with mild to moderate COPD were enrolled. The technique involves breathing i…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Foundation University Islamabad • Aim: Symptom relief
Last updated Jun 26, 2026 17:13 UTC
-
Hidden patterns: how three chronic diseases often travel together
Knowledge-focused CompletedThis completed observational study looked at 4500 patients admitted to internal medicine wards with heart failure, COPD, or chronic kidney disease. Researchers aimed to identify which other chronic conditions tend to cluster with these diseases, and how those clusters affect pati…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Fadoi Foundation, Italy • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Thinking and balancing: new study reveals hidden fall risk for COPD patients
Knowledge-focused CompletedThis study looked at how doing a mental task while standing affects balance in people with chronic lung disease (COPD). Researchers compared 36 adults with COPD to healthy volunteers to see if their balance got worse when they had to think at the same time. The goal was to better…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
COPD may weaken your ability to control leg muscles
Knowledge-focused CompletedThis study looked at whether people with COPD have trouble controlling their knee muscles during everyday tasks that require precise, gentle force. Researchers compared 36 participants (COPD patients and healthy volunteers) as they performed small, controlled leg contractions. Th…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to predict breathing muscle strength without fancy gear
Knowledge-focused CompletedThis completed observational study included 123 adults with COPD or asthma. Researchers measured breathing muscle strength using a special device and then tried to predict those results from simpler tests like spirometry and body composition. The goal was to see if doctors could …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Hitit University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Inhaler training study aims to cut COPD errors
Knowledge-focused CompletedThis study looked at how well people with COPD can learn to use three different inhaler devices: Diskus, Breezhaler, and Respimat. Twenty-four participants were taught to use each device and then checked for mistakes. The goal is to find better ways to train patients so they get …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE4 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Muscle mass may predict COPD prognosis, study finds
Knowledge-focused CompletedThis completed study from Mansoura University looked at how low fat-free mass (muscle) affects the outlook for people with COPD. Researchers studied 90 adults aged 40 and older with confirmed COPD. They used breathing tests, a 6-minute walk test, CT scans, and the BODE index to m…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Mansoura University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
SNIFF TEST: nasal swab may reveal lung disease severity
Knowledge-focused CompletedThis completed study looked at whether substances in nasal fluid can help doctors objectively measure the severity of respiratory conditions like asthma, COPD, hayfever, and sinusitis. Researchers collected samples from 111 adults (including healthy volunteers) using a small nasa…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Diag-Nose Medical Pty Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Can special breathing exercises boost muscle oxygen in COPD patients?
Knowledge-focused CompletedThis study tested two types of breathing muscle training in 24 people with COPD. One was traditional (using a handheld resistance device while sitting), and the other was functional (integrated into movement). Researchers measured muscle oxygen levels, shortness of breath, and fa…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Breathing Machine's hidden effect on swallowing revealed in COPD study
Knowledge-focused CompletedThis study looked at how breathing and swallowing interact in people with severe COPD who were in the hospital for a sudden worsening of their condition. Researchers wanted to see if using a non-invasive breathing machine (NIV) changes this interaction. Sixteen patients were obse…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Breakfast battle: whole grains vs. refined grains – which is best for you?
Knowledge-focused CompletedThis study looked at how over 1,600 people's bodies react to different breakfasts, like whole grain vs. refined grain and high-fat vs. high-carb. Researchers measured blood sugar, fats, and other markers after meals to understand why responses vary. The goal is to pave the way fo…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Chalmers University of Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Spanish study reveals Real-World impact of COPD drug trixeo
Knowledge-focused CompletedThis study looked back at the medical records of 718 adults with COPD in Spain who started taking the triple-combination inhaler Trixeo. Researchers wanted to see how many lung flare-ups (exacerbations) patients had in the year after starting the drug. The goal was to understand …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
MRI scans reveal hidden lung blood vessel problems in COPD
Knowledge-focused CompletedThis completed study used chest MRI scans to look at blood flow in the lungs of 30 people with COPD. The goal was to learn how blood vessels adapt during exercise and how this relates to disease progression. By better understanding these changes, researchers hope to improve care …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Drug interaction study for COPD inhaler: does cyclosporine change CHF6001 levels?
Knowledge-focused CompletedThis completed Phase 1 study in 30 healthy volunteers looked at how cyclosporine, a drug that blocks certain transporters, affects the amount of CHF6001 (Tanimilast) in the blood. Participants took CHF6001 alone first, then again after taking cyclosporine. The goal was to see if …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE1 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:48 UTC